Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
Clinical trial NCT03699475 · TERMINATED
Trial details
- NCT number
- NCT03699475
- Sponsor
- Bellicum Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2019-07-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.